MedicinefromNews Center1 month agoHow Inflammation Fuels Blood Cancer Risk - News CenterTP53-mutant hematopoietic stem cells gain advantage under chronic inflammation via NLRP1 inflammasome activation and altered RNA processing, driving clonal expansion and leukemia risk.
fromwww.nature.com10 months agoCancerMitochondrial metabolism sustains DNMT3A-R882-mutant clonal haematopoiesisSomatic DNMT3A R882 mutations are key drivers of clonal hematopoiesis associated with hematologic disorders.